Focus on Biochemical and Clinical Predictors of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma: Where Do We Stand?

Urothelial bladder cancer is one of the most lethal cancers worldwide with barely 5% five-year survival in patients with metastatic disease. Intravesical immunotherapy with Bacillus Calmette-Guérin and platinum-based chemotherapy are currently the standard of care for non-muscle invasive and advance...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Int J Mol Sci
Auteurs principaux: Roviello, Giandomenico, Catalano, Martina, Nobili, Stefania, Santi, Raffaella, Mini, Enrico, Nesi, Gabriella
Format: Artigo
Langue:Inglês
Publié: MDPI 2020
Sujets:
Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7662285/
https://ncbi.nlm.nih.gov/pubmed/33114616
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21217935
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires